ahlam1399
05-26-2015, 12:36 PM
AstraZeneca hit after psoriasis drug linked to suicide fears
LONDON, May 26 (Reuters) - AstraZeneca's hopes of topping $45 billion in revenue by 2023 have been dealt a blow by a problem with an experimental psoriasis drug that the drugmaker had viewed as a...http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=v_ETFB1MUGc:i9LRoBAtB0w:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=v_ETFB1MUGc:i9LRoBAtB0w:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=v_ETFB1MUGc:i9LRoBAtB0w:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=v_ETFB1MUGc:i9LRoBAtB0w:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=v_ETFB1MUGc:i9LRoBAtB0w:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/v_ETFB1MUGc
LONDON, May 26 (Reuters) - AstraZeneca's hopes of topping $45 billion in revenue by 2023 have been dealt a blow by a problem with an experimental psoriasis drug that the drugmaker had viewed as a...http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=v_ETFB1MUGc:i9LRoBAtB0w:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=v_ETFB1MUGc:i9LRoBAtB0w:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=v_ETFB1MUGc:i9LRoBAtB0w:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=v_ETFB1MUGc:i9LRoBAtB0w:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=v_ETFB1MUGc:i9LRoBAtB0w:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/v_ETFB1MUGc